APRE
Aprea Therapeutics (APRE)
$60
About Aprea Therapeutics (APRE)
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.
Details
Daily high
$2.77
Daily low
$2.15
Price at open
$2.52
52 Week High
$8.85
52 Week Low
$2.15
Market cap
14.1M
Dividend yield
0.00%
Volume
39,497
Avg. volume
26,982
P/E ratio
-.86
Aprea Therapeutics News
Details
Daily high
$2.77
Daily low
$2.15
Price at open
$2.52
52 Week High
$8.85
52 Week Low
$2.15
Market cap
14.1M
Dividend yield
0.00%
Volume
39,497
Avg. volume
26,982
P/E ratio
-.86